SERTAD2 Human (A59165)

SERTAD2 Human

SERTA Domain Containing 2 Human Recombinant

E.coli.

MGSSHHHHHH SSGLVPRGSH MGSMLGKGGK RKFDEHEDGL EGKIVSPCDG PSKVSYTLQR QTIFNISLMK LYNHRPLTEP SLQKTVLINN MLRRIQEELK QEGSLRPMFT PSSQPTTEPS DSYREAPPAF SHLASPSSHP CDLGSTTPLE ACLTPASLLE DDDDTFCTSQ AMQPTAPTKL SPPALLPEKD SFSSALDEIE ELCPTSTSTE AATAATDSVK GTSSEAGTQK LDGPQESRAD DSKLMDSLPG NFEITTSTGF LTDLTLDDIL FADIDTSMYD FDPCTSSSGT ASKMAPVSAD DLLKTLAPYS SQPVTPSQPF KMDLTELDHI MEVLVGS.

Greater than 90% as determined by SDS-PAGE.

The SERTAD2 solution (0.25mg/ml) contains 20mM Tris-HCl buffer (pH 8.0), 0.15M NaCl, 10% glycerol and 1mM DTT.

Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.

KIAA0127, MGC126688, MGC126690, Sei 2, Sei-2, Sei2, SERTA domain containing 2, SERTA domain-containing protein 2, SRTD2_HUMAN, Transcriptional regulator interacting with the PHD bromodomain 2, Transcriptional regulator interacting with the PHD-bromodomain 2, Transcriptional regulator interacting with the PHS-bromodomain 2, TRIP Br2, TRIP-Br2